Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
62
NMPA:62
Drug Approvals
Ribostamycin Sulfate Injection
- Product Name
- 硫酸核糖霉素注射液
- Approval Number
- 国药准字H34022257
- Approval Date
- May 8, 2021
NMPA
Kanamycin Sulfate Injection
- Product Name
- 硫酸卡那霉素注射液
- Approval Number
- 国药准字H34021855
- Approval Date
- May 8, 2021
NMPA
Adenosine Disodium Triphosphate Injection
- Product Name
- 三磷酸腺苷二钠注射液
- Approval Number
- 国药准字H34021857
- Approval Date
- May 8, 2021
NMPA
Gliclazide Sustained-release Tablets
- Product Name
- 格列齐特缓释片
- Approval Number
- 国药准字H20067657
- Approval Date
- Apr 29, 2021
NMPA
Citicoline Sodium Injection
- Product Name
- 胞磷胆碱钠注射液
- Approval Number
- 国药准字H19999447
- Approval Date
- Apr 29, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found